Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -828 | -26,240 | -31,849 | -21,098 | -14,673 |
| Depreciation Amortization | 140 | 223 | 227 | 100 | 75 |
| Income taxes - deferred | -407 | N/A | N/A | N/A | N/A |
| Accounts receivable | N/A | 3,086 | -7,834 | -229 | 412 |
| Accounts payable and accrued liabilities | 57 | -67 | -1,190 | -175 | 1,222 |
| Other Working Capital | 745 | 11,576 | -3,931 | -18,403 | 535 |
| Other Operating Activity | -57 | -5,886 | 8,650 | -3,688 | -7,834 |
| Operating Cash Flow | $-350 | $-17,308 | $-35,927 | $-43,493 | $-20,263 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 5,448 | 32,679 | -20,897 | 25,147 |
| PPE Investments | N/A | -82 | -253 | -291 | -79 |
| Other Investing Activity | -2,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-2,000 | $5,366 | $32,426 | $-21,188 | $25,068 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,683 | 2,874 | N/A | N/A | N/A |
| Debt Repayment | -272 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 22,402 | 10 | 54,239 | 219 |
| Other Financing Activity | 0 | -29 | 0 | 0 | 0 |
| Financing Cash Flow | $2,411 | $25,247 | $10 | $54,239 | $219 |
| Exchange Rate Effect | N/A | N/A | 9 | N/A | -40 |
| Beginning Cash Position | 6 | 14,593 | 18,075 | 28,517 | 23,533 |
| End Cash Position | 67 | 27,897 | 14,593 | 18,075 | 28,517 |
| Net Cash Flow | $61 | $13,304 | $-3,482 | $-10,442 | $4,984 |
| Free Cash Flow | |||||
| Operating Cash Flow | -350 | -17,308 | -35,927 | -43,493 | -20,263 |
| Capital Expenditure | N/A | -82 | -253 | -291 | -79 |
| Free Cash Flow | -350 | -17,390 | -36,180 | -43,784 | -20,342 |